Intermittent Fasting and Multiple Sclerosis: Evidence Review and Clinical Considerations

Current Evidence

Animal Models (EAE)

Multiple studies show intermittent fasting (IF) reduces clinical severity, demyelination, and CNS immune infiltration in experimental autoimmune encephalomyelitis (EAE). Mechanisms include ketosis, reduced mTOR signaling, enhanced autophagy, Treg expansion, and microbiome shifts.

Human Studies

  • Pilot RCT (Cignarella et al., 2018): 8 weeks of intermittent calorie restriction (600 kcal 2 days/week) in RRMS → reduced leptin, increased Tregs, improved fatigue and cognitive scores.
  • Ongoing trials: Larger RCTs testing 5:2 IF, time-restricted eating (TRE), and fasting-mimicking diets (FMD) in MS.
  • Observational data: Ramadan fasting studies show mixed results; some report transient symptom worsening, others stability.

Proposed Mechanisms in MS

  • Metabolic switching: Glucose → ketone utilization reduces oxidative stress and enhances mitochondrial efficiency in neurons.
  • Immunomodulation: Lowers pro-inflammatory cytokines (IL-6, TNF-α, IL-17), increases anti-inflammatory IL-10 and ketones (β-hydroxybutyrate inhibits NLRP3 inflammasome).
  • Gut-brain axis: Fasting alters microbiome composition, increasing beneficial taxa (Akkermansia, Faecalibacterium) that produce SCFAs.
  • Circadian alignment: TRE reinforces peripheral clocks, improving sleep and metabolic health.

Clinical Considerations

Potential Benefits

  • Fatigue reduction (most consistent finding).
  • Weight management (obesity worsens MS).
  • Insulin sensitivity improvement.
  • Possible disease-modifying effects (preliminary).

Risks & Contraindications

  • Medication interactions: DMTs requiring food (e.g., teriflunomide, fingolimod) or causing GI upset.
  • Hypoglycemia risk: Especially with insulin/sulfonylureas for comorbid diabetes.
  • Dysphagia/aspiration: If swallowing impaired, fasting may be unsafe.
  • Eating disorder history: Fasting can trigger relapse.
  • Pregnancy/lactation: Contraindicated.
  • Nutritional adequacy: Must ensure protein, micronutrients, hydration during eating windows.

Practical Guidance

  1. Consult your neurologist and a registered dietitian before starting any fasting regimen.
  2. Start gently: 12:12 TRE (12-hour fast overnight) → progress to 14:10 or 16:8 if tolerated.
  3. Hydrate abundantly during fasting (water, herbal tea, electrolytes).
  4. Monitor symptoms: Fatigue, dizziness, weakness, MS symptom changes.
  5. Track biomarkers: Vitamin D, B12, CBC, metabolic panel periodically.

Bottom Line: IF shows mechanistic promise and early clinical signals in MS, but is not yet a standard recommendation. Individualized, medically supervised approaches are essential. Fasting should complement—not replace—high-efficacy DMTs.

Fasting & Cleansing - Related Articles